Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
congenital myopathy 2C
Summary
- Definition
- A congenital myopathy that is characterized by severe congenital weakness usually resulting in death from respiratory failure in the first year or so of life and that has_material_basis_in heterozygous mutation in the ACTA1 gene on chromosome 1q42. Heterozygous mutation in the ACTA1 gene can also cause autosomal dominant typical congenital myopathy-2A (CMYP2A). Biallelic mutation in the ACTA1 gene causes autosomal recessive severe infantile congenital myopathy-2B (CMYP2B).
- Super Class
- autosomal dominant disease congenital myopathy
External Links
- Disease Ontology
- DOID:0081340
- Mondo Disease Ontology
- OMIM
Related Genes
- The Human Phenotype Ontology
| HPO ID | HPO Term |
|---|---|
| HP:0001270 | Motor delay |
| HP:0002878 | Respiratory failure |
| HP:0000276 | Long face |
| HP:0003577 | Congenital onset |
| HP:0001558 | Decreased fetal movement |
| HP:0000218 | High palate |
| HP:0002015 | Dysphagia |
| HP:0000303 | Mandibular prognathia |
| HP:0003202 | Skeletal muscle atrophy |
| HP:0001342 | Cerebral hemorrhage |
